Homes
Public Notices
News
Local news
Editor’s Pick
Pittsburgh
Local Government
Roads, Travel and Traffic
20 Years of Gas Drilling
Regional
U.S. and World
Business
Sports
HS Sports
College Sports
Penguins
Pirates
Steelers
Athlete of the Week
Wild Things
Pony Baseball
Outdoors
Columns
Opinion
Columns
Editorials
Letters to the Editor
Op Eds
Living
Neighbors
School News
Entertainment
Home and Garden
Food
Police Beat
Obituaries
Classifieds
Legal Notices
Sponsored Content
e-Edition
close
Washington County
Greene County
Mon Valley
News
Local news
Police Beat
Pittsburgh
Local Government
Roads, Travel and Traffic
Helping The Helpers
20 Years of Gas Drilling
Regional
U.S. and World
Business News
Sports
High School Sports
College Sports
Penguins
Pirates
Steelers
Wild Things
Pro Sports
Outdoors
Sports Column
Obituaries
Opinion
Columns
Editorials
Letters to the Editor
Op-Ed
Living
Neighbors
Health and Wellness
Entertainment
Home and Garden
Classifieds
Contact Us
Advertise With Us
Customer Service
Contact Information
Submission Forms
Statement of Values
Misc
Special Sections
Events
Sponsored Content
Newsletter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Neuronetics, Inc. - Common Stock
(NQ:
STIM
)
1.310
+0.010 (+0.77%)
Streaming Delayed Price
Updated: 4:00 PM EST, Nov 21, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Neuronetics, Inc. - Common Stock
< Previous
1
2
3
4
5
Next >
Top 3 Health Care Stocks Which Could Rescue Your Portfolio In November
↗
November 18, 2025
Via
Benzinga
Tuesday's pre-market session: top gainers and losers
↗
November 04, 2025
The US market session of Tuesday has yet to be opened, let's have a look at the top gainers and losers in the pre-market session today.
Via
Chartmill
NEURONETICS INC (NASDAQ:STIM) Stock Plummets 22% on Q3 2025 Revenue Miss
↗
November 04, 2025
Neuronetics (STIM) Q3 2025 results: revenue miss sparks a 22% stock drop despite a narrower-than-expected EPS loss.
Via
Chartmill
Earnings Scheduled For November 4, 2025
↗
November 04, 2025
Via
Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
↗
October 06, 2025
Via
Benzinga
Earnings Scheduled For August 5, 2025
↗
August 05, 2025
Via
Benzinga
Earnings Scheduled For May 6, 2025
↗
May 06, 2025
Via
Benzinga
Earnings Scheduled For November 12, 2024
↗
November 12, 2024
Via
Benzinga
Neuronetics Inc (NASDAQ:STIM) Reports Mixed Q2 2025 Earnings: Revenue Beat Overshadowed by Wider-Than-Expected Loss
↗
August 05, 2025
Neuronetics (STIM) reported mixed Q2 2025 results, beating revenue estimates but posting a wider-than-expected loss, causing a 9% pre-market drop. Greenbrook clinics hit record revenue.
Via
Chartmill
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
↗
May 27, 2025
Via
Benzinga
What's going on in today's pre-market session
↗
February 07, 2025
Discover the top movers in Friday's pre-market session and stay informed about market dynamics.
Via
Chartmill
12 Health Care Stocks Moving In Friday's Pre-Market Session
↗
February 07, 2025
Via
Benzinga
Earnings Scheduled For March 4, 2025
↗
March 04, 2025
Via
Benzinga
These stocks are moving in today's after hours session
↗
February 06, 2025
Let's have a look at what is happening on the US markets after the closing bell on Thursday. Below you can find the top gainers and losers in today's after hours session.
Via
Chartmill
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
↗
November 12, 2024
Via
Benzinga
Retractable Technologies And 2 Other Penny Stocks Executives Are Buying
↗
September 09, 2024
Via
Benzinga
Butterfly Network And 3 Other Stocks Under $2 Executives Are Aggressively Buying
↗
September 03, 2024
Via
Benzinga
Gold Gains Over 1%; Starbucks Shares Move Higher
↗
August 12, 2024
Via
Benzinga
Noninvasive Treatment Provider Neuronetics Agrees To Merge With Canadian Firm Greenbrook TMS; Reports Q2 Earnings And Guidance Below Expectations
↗
August 12, 2024
Neuronetics to acquire Greenbrook TMS (OTC: GBNHF) in an all-stock deal, doubling revenue to $145M. The combined company expects mid-teens growth in 2025 and 2026, with $15M in cost savings and...
Via
Benzinga
Crude Oil Surges 2%; B. Riley Financial Shares Plunge
↗
August 12, 2024
Via
Benzinga
STIM Stock Earnings: Neuronetics Misses EPS, Misses Revenue for Q2 2024
↗
August 12, 2024
STIM stock results show that Neuronetics missed analyst estimates for earnings per share and missed on revenue for the second quarter of 2024.
Via
InvestorPlace
Dow Dips 150 Points; Monday.com Posts Upbeat Earnings
↗
August 12, 2024
Via
Benzinga
Topics
Stocks
3 Neurotech Stocks Bridging Mind and Machine
↗
July 18, 2024
These neurotech stocks stand at the cutting edge of healthcare, but early entrants in new fields tend to be long-term winners.
Via
InvestorPlace
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
↗
July 10, 2024
Pre-market stock movers are worth checking out on Wednesday as we break down all of the biggest news worth reading this morning!
Via
InvestorPlace
Neuronetics And 3 Other Stocks Under $3 Insiders Are Buying
↗
June 07, 2024
Via
Benzinga
Nasdaq Moves Lower; Great Lakes Dredge & Dock Shares Surge Following Upbeat Earnings
↗
May 07, 2024
Via
Benzinga
Why Beyond Shares Are Trading Lower By Over 20%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
↗
May 07, 2024
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
↗
May 07, 2024
Via
Benzinga
Crude Oil Edges Lower; UBS Shares Jump After Q1 Earnings
↗
May 07, 2024
Via
Benzinga
STIM Stock Earnings: Neuronetics Beats EPS, Beats Revenue for Q1 2024
↗
May 07, 2024
STIM stock results show that Neuronetics beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.
Via
InvestorPlace
< Previous
1
2
3
4
5
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
Starting at $3.75
/
week.
Subscribe Today